Dr. Samer Gawrieh, MD

Dr. Gawrieh practices at Ascension St Vincent Hospital- Indianapolis in Indianapolis, Indiana.

Dr. Gawrieh's NPI, 1720039688, was assigned on May 15, 2006. Dr. Gawrieh holds Indiana license 01073090A.

Dr. Gawrieh's primary practice is Ascension St Vincent Hospital- Indianapolis, at 2001 W 86th St, Indianapolis, IN 46260 in Marion County. The practice phone is (317) 338-2172.

Dr. Gawrieh's primary practice is Ascension St Vincent Hospital- Indianapolis in Indianapolis, Indiana. Dr. Gawrieh is also affiliated with IU Health Methodist Hospital. The medical group on file is IU Health Medical Group. Dmand AI also links Dr. Gawrieh to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gawrieh practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Gawrieh's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Gawrieh's licenses on file in 2 states: Indiana and Wisconsin.

CMS data shows 216 Medicare services from Dr. Gawrieh across 8 procedure codes in 2024, for 182 Medicare patients. Medicare paid $19,534 for them.

CMS counts 182 Medicare patients who saw Dr. Gawrieh in 2024. The largest group is 65 to 74, with 80 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gawrieh's median patient age at 58, with 53% women.

In 2024, Dr. Gawrieh wrote 583 Medicare Part D claims for 134 patients. 83% of them were for generic drugs. CMS names the drug for 479 of them, across 15 drugs with 11 or more claims each, at $227,379 in total drug cost. In 2023, CMS named 341 claims across 10 drugs.

Dr. Gawrieh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gawrieh as offering telehealth.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 87 papers to Dr. Gawrieh, published from 2010 to 2025. 2023 was the busiest year, with 16. The most frequent topics are Non-alcoholic Fatty Liver Disease, Liver and Liver Cirrhosis. Dr. Gawrieh has published most often in Hepatol Commun. Dr. Gawrieh's most frequent co-authors are Naga Prasad Chalasani, MD, Lara Toufic Dakhoul, MD and Marwan Samir Ghabril, MD.

Dmand AI links Dr. Gawrieh to 5 clinical trials, 2 of them phase 2 studies. Conditions studied include Hepatitis, Alcoholic, Non-alcoholic Fatty Liver Disease and Fatty Liver. Indiana University sponsors the most, 4.

CMS Open Payments shows 28 general payments to Dr. Gawrieh from 3 drug and device companies from 2021 to 2025. Consulting fees make up the largest share, 100% of the total. TransMedics, Inc. paid the most, $72,000. It also lists 24 research payments totaling $75,075 from 2017 to 2020.